GlaxoSmithKline (GSK) Tops Q2 EPS by 4c
Tweet
Share
E-mail
Get Alerts GSK Hot Sheet
Join SI Premium – FREE
GlaxoSmithKline (NYSE: GSK) reported Q2 EPS of GBP0.25, GBP0.04 better than the analyst estimate of GBP0.21. Revenue for the quarter came in at GBP6.35 billion versus the consensus estimate of GBP6.34 billion.
For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Bristow Group to acquire Berry Aviation for $105 million
- Deutsche Bank Starts DexCom (DXCM) at Buy
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
